Celia Requena

6.6k total citations
235 papers, 3.6k citations indexed

About

Celia Requena is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Celia Requena has authored 235 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Oncology, 101 papers in Dermatology and 80 papers in Epidemiology. Recurrent topics in Celia Requena's work include Cutaneous Melanoma Detection and Management (79 papers), Nonmelanoma Skin Cancer Studies (49 papers) and Vascular Tumors and Angiosarcomas (33 papers). Celia Requena is often cited by papers focused on Cutaneous Melanoma Detection and Management (79 papers), Nonmelanoma Skin Cancer Studies (49 papers) and Vascular Tumors and Angiosarcomas (33 papers). Celia Requena collaborates with scholars based in Spain, Germany and United States. Celia Requena's co-authors include Eduardo Nagore, B. Llombart, V. Través, Luís Requena, C. Serra‐Guillén, Rafael Botella‐Estrada, O. Sanmartín, C. Guillén, Heinz Kutzner and Onofre Sanmartín and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Celia Requena

223 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Celia Requena 1.8k 1.4k 870 784 472 235 3.6k
Kee Yang Chung 874 0.5× 1.3k 0.9× 665 0.8× 899 1.1× 259 0.5× 211 3.5k
Wain L. White 1.2k 0.7× 1.0k 0.7× 1.2k 1.3× 637 0.8× 381 0.8× 106 3.4k
Hisashi Uhara 2.1k 1.2× 894 0.6× 873 1.0× 829 1.1× 274 0.6× 158 3.2k
Ronald J. Barr 1.3k 0.7× 1.6k 1.2× 1000 1.1× 492 0.6× 467 1.0× 153 3.7k
John C. Maize 1.4k 0.8× 1.2k 0.9× 1.0k 1.2× 751 1.0× 249 0.5× 135 3.8k
David Weedon 1.0k 0.6× 1.2k 0.9× 1.4k 1.6× 563 0.7× 321 0.7× 129 3.3k
Ronald P. Rapini 940 0.5× 956 0.7× 702 0.8× 393 0.5× 276 0.6× 96 2.6k
Pietro Rubegni 1.9k 1.1× 1.2k 0.9× 937 1.1× 358 0.5× 122 0.3× 254 3.5k
Rafael Botella‐Estrada 1.0k 0.6× 1.0k 0.7× 754 0.9× 371 0.5× 166 0.4× 187 2.3k
Loren E. Golitz 1.0k 0.6× 955 0.7× 744 0.9× 516 0.7× 232 0.5× 69 2.6k

Countries citing papers authored by Celia Requena

Since Specialization
Citations

This map shows the geographic impact of Celia Requena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Requena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Requena more than expected).

Fields of papers citing papers by Celia Requena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia Requena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Requena. The network helps show where Celia Requena may publish in the future.

Co-authorship network of co-authors of Celia Requena

This figure shows the co-authorship network connecting the top 25 collaborators of Celia Requena. A scholar is included among the top collaborators of Celia Requena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia Requena. Celia Requena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López-Reig, Raquel, Emmanuel Giner, Antonio Fernández‐Serra, et al.. (2025). Integration of an OS-Based Machine Learning Score (AS Score) and Immunoscore as Ancillary Tools for Predicting Immunotherapy Response in Sarcomas. Cancers. 17(15). 2551–2551.
2.
Nagore, Eduardo, et al.. (2024). [Translated article] Avelumab to treat Merkel cell carcinoma: real-life experience in a dedicated oncology center. Actas Dermo-Sifiliográficas. 116(1). T81–T86. 1 indexed citations
3.
Nagore, Eduardo, et al.. (2024). Combined Merkel Cell Carcinoma and Squamous Cell Carcinoma: A Systematic Review. Cancers. 16(2). 411–411. 7 indexed citations
4.
García‐Casado, Zaida, et al.. (2022). Differences by Anatomical Site of Non-Acral Lentiginous Melanomas of the Lower Limb. Dermatology. 238(5). 977–985. 2 indexed citations
5.
Peña-Chilet, María, Zaida García‐Casado, Celia Requena, et al.. (2021). Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma Development. Cancers. 13(20). 5219–5219. 7 indexed citations
6.
Barreiro, Alicia, Sebastián Podlipnik, Cristina Carrera, et al.. (2021). Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study. European Journal of Cancer. 145. 29–37. 12 indexed citations
7.
Diago, A., B. Llombart, C. Serra‐Guillén, et al.. (2021). Usefulness of ultrasound in dermatofibrosarcoma protuberans and correlation with histopathological findings: A series of 30 cases. Skin Research and Technology. 27(5). 701–708. 13 indexed citations
8.
9.
Boada, Aram, A. Tejera‐Vaquerizo, Simone Ribero, et al.. (2020). Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis. Journal of the European Academy of Dermatology and Venereology. 34(9). e513–e517. 5 indexed citations
10.
Virós, Amaya, et al.. (2019). Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions. JAMA Dermatology. 155(7). 782–782. 14 indexed citations
11.
Rachakonda, P. Sivaramakrishna, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.. (2018). Telomere length and survival in primary cutaneous melanoma patients. Scientific Reports. 8(1). 10947–10947. 18 indexed citations
12.
Murillo-Ortíz, Blanca, et al.. (2016). Niveles de 25-hidroxivitamina D en pacientes con melanoma y factores asociados con su insuficiencia. Actas Dermo-Sifiliográficas. 107(9). 758–764. 4 indexed citations
13.
Lara, Pablo Espinosa, Ruth M. Pfeiffer, Zaida García‐Casado, et al.. (2015). Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study. European Journal of Cancer. 53. 115–124. 15 indexed citations
14.
Serra‐Guillén, C., B. Llombart, Eduardo Nagore, et al.. (2013). High immunohistochemical nestin expression is associated with greater depth of infiltration in dermatofibrosarcoma protuberans: a study of 71 cases. Journal of Cutaneous Pathology. 40(10). 871–878. 10 indexed citations
15.
Requena, Celia, F. Messeguer, B. Llombart, C. Serra‐Guillén, & Carlos Guillén. (2012). Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. International Journal of Dermatology. 51(4). 451–454. 7 indexed citations
16.
Messeguer, F., C. Serra‐Guillén, Begoña Echeverría, et al.. (2011). A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod. Journal of the European Academy of Dermatology and Venereology. 26(7). 879–881. 11 indexed citations
17.
Alfaro‐Rubio, A., Rafael Botella‐Estrada, C. Serra‐Guillén, et al.. (2010). Liquen plano anular y atrófico. Revista Medicina Cutánea Ibero-Latino-Americana. 38(1). 41–44.
18.
Messeguer, F., Eduardo Nagore, Celia Requena, & C. Guillén-Barona. (2010). Management of Basal Cell Carcinoma with Perineural Invasion. Actas Dermo-Sifiliográficas. 101(9). 805–806. 1 indexed citations
19.
Nagore, Eduardo, B. Llombart, O. Sanmartín, et al.. (2006). Basal cell carcinoma of the nasolabial fold: an apparently ‘benign’ tumour that often needs complex surgery. Journal of the European Academy of Dermatology and Venereology. 20(8). 926–930. 9 indexed citations
20.
Requena, Celia, et al.. (2000). Eritema tóxico neonatal pustuloso. Actas Dermo-Sifiliográficas. 91(6). 289–290. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026